Schellekens_BLongum_Obesity_Stress_EBIOM_103176 (003)

H. Schellekens et al. / EBioMedicine xxx (xxxx) 103176


[13] P. Maruvada, V. Leone, L.M. Kaplan, E.B Chang The human microbiome and obesity: moving beyond associations. Cell Host Microbe 2017;22(5):589 – 599. [14] F. Backhed, H. Ding, T. Wang, L.V. Hooper, G.Y. Koh, A. Nagy, et al. The gut microbiota as an environmental factor that regulates fat storage. PNAS 2004;101(44):15718 – 15723. [15] R.E. Ley, P.J. Turnbaugh, S. Klein, J.I Gordon Microbial ecology - Human gut microbes associated with obesity. Nature 2006;444(7122):1022 – 1023. [16] R.E. Ley, F. Backhed, P. Turnbaugh, C.A. Lozupone, R.D. Knight, J.I Gordon Obesity alters gut microbial ecology. PNAS 2005;102(31):11070 – 11075. [17] V.K. Ridaura, J.J. Faith, F.E. Rey, J. Cheng, A.E. Duncan, A.L. Kau, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013;341(6150):1241214. [18] C.A. Thaiss, S. Itav, D. Rothschild, M. Meijer, M. Levy, C. Moresi, et al. Persistent microbiome alterations modulate the rate of post-dieting weight regain. Nature 2016. [19] R.A.H. Adan, E.M. van der Beek, J.K. Buitelaar, J.F. Cryan, J. Hebebrand, S. Higgs, et al. Nutritional psychiatry: towards improving mental health by what you eat. Eur Neuropsychopharmacol 2019;29(12):1321 – 1332. [20] G. Ezra-Nevo, S.F. Henriques, C Ribeiro The diet-microbiome tango: how nutrients lead the gut brain axis. Curr Opin Neurobiol 2020;62:122 – 132. [21] M.J. Khan, K. Gerasimidis, C.A. Edwards, M.G Shaikh Role of gut microbiota in the aetiology of obesity: proposed mechanisms and review of the literature. J Obes 2016;2016:7353642. [22] P.D. Cani, N.M Delzenne The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009;15(13):1546 – 1558. [23] S.O Fetissov Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour. Nat Rev Endocrinol 2017;13(1):11 – 25. [24] K.V. Sandhu, E. Sherwin, H. Schellekens, C. Stanton, T.G. Dinan, J.F Cryan Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry. Transl Res 2017;179:223 – 244. [25] Everard A., Cani P.D. Gut microbiota and GLP-1. Reviews in endocrine & meta- bolic disorders. 2014;15(3):189 – 96. [26] F.A. Duca, T.D. Swartz, Y. Sakar, M Covasa Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS ONE 2012;7(6):e39748. [27] M.I. Queipo-Ortuno, L.M. Seoane, M. Murri, M. Pardo, J.M. Gomez-Zumaquero, F. Cardona, et al. Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels. PLoS ONE 2013;8(5):e65465. [28] J.A. Parnell, R.A Reimer Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 2009;89(6):1751 – 1759. [29] J. Peng, X. Xiao, M. Hu, X Zhang Interaction between gut microbiome and cardiovascular disease. Life Sci 2018;214:153 – 157. [30] H. Rajkumar, N. Mahmood, M. Kumar, S.R. Varikuti, H.R. Challa, S.P Myakala Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial. Mediat Inflamm 2014;2014:348959. [31] J. Kim, J.M. Yun, M.K. Kim, O. Kwon, B Cho Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: a randomized, double-blind, placebo-controlled trial. J Med Food 2018;21(5):454 – 461. [32] S.P. Jung, K.M. Lee, J.H. Kang, S.I. Yun, H.O. Park, Y. Moon, et al. Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: a randomized, double-blind clinical trial. Korean J Fam Med 2013;34(2):80 – 89. [33] S. Sabico, A. Al-Mashharawi, N.M. Al-Daghri, S. Yakout, A.M. Alnaami, M.S. Alokail, et al. Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naive T2DM patients: a randomized clinical trial. J Transl Med 2017;15(1):249. [34] M. Zarrati, E. Salehi, K. Nourijelyani, V. Mofid, M.J. Zadeh, F. Najafi, et al. Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet. J Am Coll Nutr 2014;33(6):417 – 425. [35] L.K. Stenman, M.J. Lehtinen, N. Meland, J.E. Christensen, N. Yeung, M.T. Saarinen, et al. Probiotic with or without fiber controls body fat mass, associated with serum zonulin, in overweight and obese adults-randomized controlled trial. EBioMedicine 2016;13:190 – 200. [36] A.A. Hibberd, C.C. Yde, M.L. Ziegler, A.H. Honore, M.T. Saarinen, S. Lahtinen, et al. Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults. Benef Microb 2019;10(2):121 – 135. [37] C. Torres-Fuentes, A.V. Golubeva, A.V. Zhdanov, S. Wallace, S. Arboleya, D.B. Papkovsky, et al. Short-chain fatty acids and microbiota metabolites attenuate ghrelin receptor signaling. FASEB J 2019. fj201901433R. [38] M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, K Kangawa Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402(6762):656 – 660. [39] T.D. Muller, R. Nogueiras, M.L. Andermann, Z.B. Andrews, S.D. Anker, J. Argente, et al. Ghrelin. Mol Metab 2015;4(6):437 – 460. [40] M. Nakazato, N. Murakami, Y. Date, M. Kojima, H. Matsuo, K. Kangawa, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409(6817):194 – 198. [41] M. Tschop, D.L. Smiley, M.L Heiman Ghrelin induces adiposity in rodents. Nature 2000;407(6806):908 – 913. [42] D.E. Cummings, J.Q. Purnell, R.S. Frayo, K. Schmidova, B.E. Wisse, D.S Weigle A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50(8):1714 – 1719. [43] C.W. le Roux, M. Patterson, R.P. Vincent, C. Hunt, M.A. Ghatei, S.R Bloom Postprandial plasma ghrelin is suppressed proportional to meal calorie content

in normal-weight but not obese subjects. J Clin Endocr Metab 2005;90(2):1068 – 1071. [44] B.O. Yildiz, M.A. Suchard, M.L. Wong, S.M. McCann, J Licinio Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. PNAS 2004;101(28):10434 – 10439. [45] K. Howick, B.T. Griffin, J.F. Cryan, H Schellekens From belly to brain: targeting the ghrelin receptor in appetite and food intake regulation. Int J Mol Sci 2017;18(2). [46] A. Abizaid, T.L. Horvath Ghrelin and the central regulation of feeding and energy balance. Indian J Endocrinol Metab 2012;16(Suppl 3):S617 – S626. [47] A Abizaid Ghrelin and dopamine: new insights on the peripheral regulation of appetite. J Neuroendocrinol 2009;21(9):787 – 793. [48] E. Takeshita, B. Matsuura, M. Dong, L.J. Miller, H. Matsui, M Onji Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract. J Gastroenterol 2006;41(3):223 – 230. [49] J. Suez, T. Korem, D. Zeevi, G. Zilberman-Schapira, C.A. Thaiss, O. Maza, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014;514(7521):181 – 186. [50] K.J. Livak, T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25(4):402 – 408. [51] R.B. Haynes, D.W. Taylor, D.L. Sackett, E.S. Gibson, C.D. Bernholz, J Mukherjee Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2(6):757 – 764. [52] L.J. Bernini, A.N. Simao, D.F. Alfieri, M.A. Lozovoy, N.L. Mari, C.H. de Souza, et al. Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: a randomized trial. Effects of probiotics on metabolic syndrome. Nutrition. 2016;32(6):716 – 719. [53] B.J. Chang, S.U. Park, Y.S. Jang, S.H. Ko, N.M. Joo, S.I. Kim, et al. Effect of functional yogurt NY-YP901 in improving the trait of metabolic syndrome. Eur J Clin Nutr 2011;65(11):1250 – 1255. [54] A.C. Gomes, R.G. de Sousa, P.B. Botelho, T.L. Gomes, P.O. Prada, J.F Mota The additional effects of a probiotic mix on abdominal adiposity and antioxidant Status: a double-blind, randomized trial. Obesity 2017;25(1):30 – 38. [55] T. Stalder, C. Kirschbaum, B.M. Kudielka, E.K. Adam, J.C. Pruessner, S. Wust, et al. Assessment of the cortisol awakening response: expert consensus guidelines. Psychoneuroendocrinology 2016;63:414 – 432. [56] A. Burokas, S. Arboleya, R.D. Moloney, V.L. Peterson, K. Murphy, G. Clarke, et al. Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry 2017. [57] N. Segata, J. Izard, L. Waldron, D. Gevers, L. Miropolsky, W.S. Garrett, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12(6):R60. [58] Z. Yu, M. Morrison Improved extraction of PCR-quality community DNA from digesta and fecal samples. BioTechniques 2004;36(5):808 – 812. [59] A.D. Fernandes, J.N. Reid, J.M. Macklaim, T.A. McMurrough, D.R. Edgell, G.B Gloor Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. Microbiome 2014;2:15. [60] T.C. Hsieh, A Chao Rarefaction and extrapolation: making fair comparison of abundance-sensitive phylogenetic diversity among multiple assemblages. Syst Biol 2017;66(1):100 – 111. [61] S. Cohen, T. Kamarck, R Mermelstein A global measure of perceived stress. J Health Soc Behav 1983;24(4):385 – 396. [62] A.S. Zigmond, R.P. Snaith The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6):361 – 370. [63] C.L. Craig, A.L. Marshall, M. Sjostrom, A.E. Bauman, M.L. Booth, B.E. Ainsworth, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35(8):1381 – 1395. [64] J. Harrington, A.P. Fitzgerald, R. Layte, J. Lutomski, M. Molcho, I.J Perry Sociodemographic, health and lifestyle predictors of poor diets. Public Health Nutr 2011;14(12):2166 – 2175. [65] B.G. Tabachnick, L.S Fidell Using multivariate statistics. 6 ed; 2012 June 15. [66] J. Jarolimova, J. Tagoni, T.A Stern Obesity: its epidemiology, comorbidities, and management. Prim Care Companion CNS Disord 2013;15(5). [67] G. Lach, H. Schellekens, T.G. Dinan, J.F Cryan Anxiety, depression, and the microbiome: a role for gut peptides. Neurotherapeutics 2018;15(1):36 – 59. [68] S.F. Clarke, E.F. Murphy, K. Nilaweera, P.R. Ross, F. Shanahan, P.W. O ’ Toole, et al. The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes 2012;3(3):186 – 202. [69] I. Nadal, A. Santacruz, A. Marcos, J. Warnberg, J.M. Garagorri, L.A. Moreno, et al. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int J Obes (Lond) 2009;33(7):758 – 767. [70] C. Torres-Fuentes, H. Schellekens, T.G. Dinan, J.F Cryan The microbiota-gut-brain axis in obesity. Lancet Gastroenterol Hepatol 2017;2(10):747 – 756. [71] B.S. Sivamaruthi, P. Kesika, N. Suganthy, C Chaiyasut A review on role of microbiome in obesity and antiobesity properties of probiotic supplements. Biomed Res Int 2019;2019:3291367. [72] G. Muscogiuri, E. Cantone, S. Cassarano, D. Tuccinardi, L. Barrea, S. Savastano, et al. Gut microbiota: a new path to treat obesity. Int J Obes Suppl 2019;9(1):10 – 19. [73] J.M. Zigman, S.G. Bouret, Z.B Andrews Obesity impairs the action of the neuroendocrine ghrelin system. Trends Endocrinol Metab 2016;27(1):54 – 63. [74] D.E. Cummings Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 2006;89(1):71 – 84. [75] M. Tschop, C. Weyer, P.A. Tataranni, V. Devanarayan, E. Ravussin, M.L Heiman Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50(4):707 – 709.

Powered by